CLS Holdings USA, Inc. (OTC US:CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cann-a-bis subsidiaries in Nevada and plans to expand to other states. CLS stands for “Cann-a-bis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation, and consulting services. https://www.clsholdingsinc.com/
Today, the company released a press release reviewing the financial and operational highlights that made 2021 the most successful and transformational year to date, and releases its initial 2022 outlook.
2021 Highlights and 2022 Outlook:
1. Despite the Nevada cann-a-bis market decelerating in 2021, CLS saw net revenues increase 44% year over year (1)
2. CLS entered into two important joint ventures, which should transform the Company and add substantial revenue at attractive margins (1)
3. City Trees achieved a 6.5% brand market share, according to BDS Analytics, with leading market share positions across key categories (1)
4. For the calendar year 2022, we are projecting substantial net revenue growth while maintaining current gross margins and increasing EBITDA (1)
Click HERE to read more about this exciting small cap company.
Earlier On Jan 13th, CLS Holdings USA, Inc. (OTC US:CLSH) had announced its operational and financial results for the second quarter of fiscal 2022, ended November 30, 2021. As per the press release, the Company saw meaningful revenue growth for the quarter ended November 30, 2021 with an increase in revenue of 10% compared to the quarter ending November 30, 2020. Revenue growth at City Trees proved to be significant with an increase of 55% compared to last year’s Q2 numbers (2) Company President & COO Andrew Glashow stated “This is a testament to the traction the brand has gained over the past year and its loyal customer base. Our ability to offer a consistently reputable and reliable product at an affordable price has been our strong suit and the brand’s continued growth is a powerful indication of its resonance with consumers (2).
Trading at a mere $0.07, CLSH could be highly undervalued. As always, conduct your own due diligence.
Other stocks in similar sector to place on top of watch list are Tilray Inc. (NASDAQ:TLRY), Trulieve Cannabis Corp. (OTC US:TCNNF), Curaleaf Holdings Inc. (OTC US:CURLF), Aurora Cannabis Inc. (NASDAQ:ACB), Canopy Growth Corp. (NASDAQ:CGC), Organigram Holdings Inc. (NASDAQ:OGI), Cronos Group Inc. (NASDAQ:CRON).
Source 1- https://finance.yahoo.com/quote/clsh/
Source 2- https://finance.yahoo.com/news/outperforming-market-cls-holdings-usa-110000736.html
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com